Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Polymer Factory Sweden

0,70 SEK

Mindre end 1K følgere

POLYMER

Nordic SME

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
0,00 %
-16,17 %
-25,93 %
-26,32 %
-22,22 %
+13,82 %
-74,22 %
-
-91,08 %

Polymer Factory Sweden specializes in nanotechnology. The company develops polymeric materials that are used in various medical treatments. The solutions are mainly used as a complement in various treatments for cancer and neurological diseases. In addition to the main business, companies offer calibration technology that is used in various analysis and food testing.

Læs mere
Markedsværdi
11,32 mio. SEK
Aktieomsætning
-
Omsætning
1,69 mio.
EBIT %
-243,2 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
17.2
2026

Årsrapport '25

5.6
2026

Generalforsamling '26

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse14.11.2025, 07.00

Polymer Factory Sweden AB (publ) Interim Report Q3 2025

Polymer Factory Sweden
Selskabsmeddelelse30.9.2025, 13.00

Change of Management in Polymer Factory Sweden AB (publ)

Polymer Factory Sweden
Selskabsmeddelelse17.9.2025, 06.00

Polymer Factory Receives Approx. SEK 2.05 Million Through 100% Exercise of Warrants of Series TO1

Polymer Factory Sweden

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse29.8.2025, 06.00

Polymer Factory Granted Dendritic Nanogel (DNG) Patent in Multiple European Countries

Polymer Factory Sweden
Selskabsmeddelelse18.8.2025, 06.00

Polymer Factory Granted SpheriCal Patent in Multiple European Countries

Polymer Factory Sweden
Selskabsmeddelelse15.8.2025, 06.00

Polymer Factory Sweden (publ) Interim report Q2 2025

Polymer Factory Sweden
Selskabsmeddelelse8.8.2025, 06.54

Polymer Factory: Breakthrough in Cancer Drug Delivery: Polymer-Based Nanocarriers Show Promise Against Aggressive Tumors

Polymer Factory Sweden
Selskabsmeddelelse11.7.2025, 13.38

Polymer Factory Sweden AB Completes Strategic Delivery to Leading Biopharmaceutical Company

Polymer Factory Sweden
Selskabsmeddelelse3.6.2025, 18.24

Communication from Polymer Factory Sweden AB's Annual General Meeting 2025

Polymer Factory Sweden
Selskabsmeddelelse1.6.2025, 09.55

Bruker launches QSee™ in partnership with Polymer Factory

Polymer Factory Sweden
Selskabsmeddelelse21.5.2025, 08.23

Polymer Factory Receives Order from International Energy Company

Polymer Factory Sweden
Selskabsmeddelelse16.5.2025, 05.00

Polymer Factory Sweden (publ) Interim report Q1 2025

Polymer Factory Sweden
Selskabsmeddelelse30.4.2025, 11.01

Notice of annual general meeting in Polymer Factory Sweden AB

Polymer Factory Sweden
Selskabsmeddelelse28.4.2025, 11.05

Polymer Factory Signs Supply Agreement with Global Leader in Scientific Instrumentation

Polymer Factory Sweden
Selskabsmeddelelse7.4.2025, 08.59

Polymer Factory Sweden AB receives a substantial order

Polymer Factory Sweden
Selskabsmeddelelse17.2.2025, 06.42

Polymer Factory Sweden (publ) Interim report Q4 2024

Polymer Factory Sweden
Selskabsmeddelelse12.2.2025, 10.23

Polymer Factory Sweden AB secures order from a leading biopharma company in the US

Polymer Factory Sweden
Pressemeddelelse27.12.2024, 15.14

Polymer Factory: Patent granted for Dendritic Nanogel carriers (DNG) in China

Polymer Factory Sweden
Pressemeddelelse17.12.2024, 07.15

Polymer Factory signs distribution agreement for SpheriCal® in Japan

Polymer Factory Sweden
Selskabsmeddelelse9.12.2024, 07.40

Polymer Factory Sweden AB secures order of approx. SEK 415,000 from leading biopharmaceutical company

Polymer Factory Sweden
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.